Sharp Therapeutics Corp. (TSXV:SHRX)
3.950
-0.250 (-5.95%)
At close: Nov 18, 2025
79.55% (1Y)
| Market Cap | 118.54M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -4.63M |
| Shares Out | 30.01M |
| EPS (ttm) | -0.15 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 500 |
| Average Volume | 4,000 |
| Open | 3.940 |
| Previous Close | 4.200 |
| Day's Range | 3.940 - 3.950 |
| 52-Week Range | 0.230 - 5.000 |
| Beta | -1.47 |
| RSI | 54.25 |
| Earnings Date | Nov 28, 2025 |